Clinical Trial Update: Ixovex-1 Single Agent and Combination Therapy [Phase 1, Phase 2]

View source ↗

Summary

Ixovex-1 is being studied as a single-agent and combination therapy in Phase 1/Phase 2 trials for solid tumors including head and neck cancer, with recruitment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Solid Tumor

Drugs mentioned

• Ixovex-1

Snippet

Sponsor: Psivac Ltd | Conditions: Solid Tumor, Head and Neck Cancer | Phase 1, Phase 2 | Status: RECRUITING